What is Gene By Gene?
Gene By Gene, operating under the GenomX brand, offers a Clinical Reporting Application designed to revolutionize the management of clinical reports within healthcare systems. This platform integrates analysis data with electronic lab ordering and results distribution, providing healthcare providers and clinicians with a unified solution to enhance productivity and reduce operational costs. The system prioritizes data security, adhering to HIPAA-compliant cloud storage protocols, and features customizable reports and intuitive dashboards. GenomX's core objective is to facilitate the seamless and efficient sharing of patient lab reports among multiple clinicians, positioning it as a critical tool for modern healthcare practices.
How much funding has Gene By Gene raised?
Gene By Gene has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
What's next for Gene By Gene?
The recent major strategic investment in Gene By Gene signals a pivotal moment for the company, likely enabling expansion of its clinical reporting solutions and further integration into enterprise healthcare systems. This capital infusion is expected to fuel product development, enhance market penetration, and potentially broaden its service offerings. The company's focus on streamlining complex reporting processes and ensuring data security aligns with the growing demand for digital health solutions, suggesting a trajectory towards increased adoption and market leadership in the healthcare IT sector.
See full Gene By Gene company page
